US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

KraneShares MSCI All China Health Care Index ETF

18.31

+0.57003.21%

Post-market: 18.310.00000.00%16:10 EDT

Volume:26.07K

Turnover:476.69K

Market Cap:108.03M

PE:- -

High:18.36

Open:18.30

Low:18.11

Close:17.74

52wk High:21.50

52wk Low:14.38

Shares:5.90M

Float Shares:5.90M

Volume Ratio:0.47

T/O Rate:0.44%

Dividend:0.71

Dividend Rate:3.90%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Transcenta Licenses HiCB Bioprocessing Technology to WuXi Biologics for RMB 10 Million Upfront

Transcenta Holding - to Receive RMB 10 Mln Upfront Payment and Milestone Payments

THOMSON REUTERS

Transcenta Holding - Grants WuXi Biologics Non-Exclusive License to Hicb Platform and Excelpro Cell Culture Media

THOMSON REUTERS

CSPC Pharma Gets Clinical Trial Nod in China for Solid Tumors Drug

MT Newswires Live

CSPC Pharmaceutical Says Rotigotine Long-Acting Injection Gets Clinical Trial Approval in China

CSPC Pharma's Goserelin Extended-Release Injection Gets Clinical Trial Green Light in China

CSPC Pharma Gains Chinese Clinical Trial Approval for Goserelin Extended-Release Injection

CSPC Pharma Wins China Clinical Trial Clearance for Syh9102 Goserelin Injection

CSPC Pharmaceutical - Goserelin Sustained-Release Injection (Syh9102 Injection) Obtains Clinical Trial Approval in China

THOMSON REUTERS

CLSA Highlights Return of Stock-Specific Drivers in China's Innovative Drug Sector, Sees Macro Swings as Entry Points

CSPC Pharmaceutical Gets China Approval for Eye Drug Clinical Trials

MT Newswires Live

CSPC Wins China Clinical Trial Approval for Syh2083 Dry Eye Drops

CSPC Pharmaceutical - Syh2083 Eye Drops Obtain Clinical Trial Approval in China

THOMSON REUTERS

Wuxi Biologics (Cayman) Stock Climbs 1.7% in Hong Kong

CSPC Pharmaceutical Group Stock Falls 2.7% in Hong Kong, Underperforms Competitors

Market Bets on BOJ Rate Hike While CICC's Merger Wins Regulatory Approval

CSPC Pharma Begins Phase II Study of Influenza Drug in China

MT Newswires Live

Fourth Breakthrough Therapy Designation Granted to EGFR-Targeted ADC Developed by CSPC

WuXi Biologics Files HKEX Next-Day Disclosure Return, Issues 1,804,090 New Shares

CSPC Pharma Initiates Phase II Trial of SYH2085 Tablet for Uncomplicated Influenza in Chinese Adults

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/KURE/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"KURE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","market":"US","secType":"STK","nameCN":"KraneShares MSCI All China Health Care Index ETF","latestPrice":18.31,"timestamp":1789416000000,"preClose":17.74,"halted":0,"volume":26065,"hourTrading":{"tag":"盘后","latestPrice":18.31,"preClose":18.31,"latestTime":"16:10 EDT","volume":10,"amount":183.1,"timestamp":1789416604439,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.032130777903043986,"floatShares":5900168,"shares":5900168,"eps":0,"marketStatus":"Post-Mkt","change":0.57,"latestTime":"09-14 17:17:37 EDT","open":18.3,"high":18.3599,"low":18.1101,"amount":476691,"amplitude":0.014081,"askPrice":19.92,"askSize":100,"bidPrice":16.63,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789430400000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":17.74,"sharesOutstanding":4750002,"nav":17.75,"aum":104708978.23,"dividendRate":0.039039,"bidAskSpread":0.008219,"postHourTrading":{"tag":"盘后","latestPrice":18.31,"preClose":18.31,"latestTime":"16:10 EDT","volume":10,"amount":183.1,"timestamp":1789416604439,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.466743,"impliedVol":0.2574,"impliedVolPercentile":0.5139},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","floatShares":5900168,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.466743,"shares":5900168,"dividePrice":0.7148,"high":18.3599,"amplitude":0.014081,"preClose":17.74,"low":18.1101,"week52Low":14.3797,"pbRate":"--","week52High":21.5,"institutionHeld":0,"latestPrice":18.31,"eps":0,"divideRate":0.039039,"volume":26065,"delay":0,"ttmEps":0,"open":18.3,"prevYearClose":17.04,"prevWeekClose":17.74,"prevMonthClose":18.54,"prevQuarterClose":15.747,"fiveDayClose":18.9,"twentyDayClose":18.43,"sixtyDayClose":14.56},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KURE\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"KURE","amount":0.714689,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-23","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-23"},{"date":"2024-12-17","symbol":"KURE","amount":0.18361,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-18","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-18"},{"date":"2023-12-18","symbol":"KURE","amount":0.112844,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2023-12-20","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-20"},{"market":"US","date":"2022-12-28","symbol":"KURE","amount":0.010399,"defaultRemindTime":1672237800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2022-12-30","payableDate":"2022-12-29","currency":"USD","type":"dividend","dateTimestamp":1672203600000},{"market":"US","date":"2021-12-29","symbol":"KURE","amount":4.053448,"defaultRemindTime":1640788200000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2021-12-31","payableDate":"2021-12-30","currency":"USD","type":"dividend","dateTimestamp":1640754000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KURE\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-26","recordDate":"2018-12-27","paymentDate":"2018-12-28","value":0.039344,"currency":"USD"},{"executeDate":"2019-12-27","recordDate":"2019-12-30","paymentDate":"2019-12-31","value":0.057325,"currency":"USD"},{"executeDate":"2020-12-29","recordDate":"2020-12-30","paymentDate":"2020-12-31","value":0.000109,"currency":"USD"},{"executeDate":"2021-12-29","recordDate":"2021-12-30","paymentDate":"2021-12-31","value":4.053448,"currency":"USD"},{"executeDate":"2022-12-28","recordDate":"2022-12-29","paymentDate":"2022-12-30","value":0.010399,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KURE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KURE\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666538664","title":"Transcenta Licenses HiCB Bioprocessing Technology to WuXi Biologics for RMB 10 Million Upfront","url":"https://stock-news.laohu8.com/highlight/detail?id=2666538664","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666538664?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:03","pubTimestamp":1788955391,"startTime":"0","endTime":"0","summary":"Transcenta licenses HiCB bioprocessing technology to WuXi Biologics for RMB 10 million upfrontTranscenta entered a technology licensing and strategic collaboration agreement with WuXi Biologics coveri","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDLbxChqk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0051755006.USD","KURE","LU0128526141.USD","LU0039217434.USD","LU0823397103.USD","BK0187","LU1242518857.USD","LU0516422366.SGD","LU0572944931.SGD","BK0183","LU1997245177.USD","LU2213484517.USD","LU0307460666.USD","SG9999001226.SGD","BK1141","LU0823426308.USD","02269","LU0456846285.SGD","LU0588546209.SGD","LU0029874061.USD","LU1688375341.USD","LU0320764599.SGD","LU0140636845.USD","LU0417516902.SGD","LU0516423091.SGD","LU0181495838.USD","SG9999002562.SGD","LU0823426480.USD","601939","LU0043850808.USD","LU0456827905.SGD","BK1521","LU2289578879.USD","BK1161","BK0015","06628","LU1064131003.USD","SG9999006597.SGD","LU0417516738.SGD","LU2039709279.SGD","LU1997244956.HKD","LU1064130708.USD","LU0052750758.USD","LU0823413660.USD","IE00B0JY6N72.USD","LU2148510915.USD","LU1880383366.USD","SGXZ90724238.SGD","BK1610","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666538344","title":"Transcenta Holding - to Receive RMB 10 Mln Upfront Payment and Milestone Payments","url":"https://stock-news.laohu8.com/highlight/detail?id=2666538344","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666538344?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:00","pubTimestamp":1788955210,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA8NNVMW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0307460666.USD","LU1794554557.SGD","LU1688375341.USD","LU0052750758.USD","LU0326950275.SGD","LU0327786744.USD","LU0181495838.USD","LU0456827905.SGD","LU0819121731.USD","LU0128526141.USD","LU1880383366.USD","LU0708995583.HKD","LU0516423174.USD","LU0051755006.USD","IE00B0JY6N72.USD","LU0029874061.USD","LU0359202008.SGD","LU1242518857.USD","BK1589","LU0043850808.USD","BK1576","LU0348735423.USD","SG9999002463.SGD","LU1720050803.USD","LU0516422366.SGD","LU2039709279.SGD","LU0516422440.USD","LU0823426480.USD","BK1141","BK1610","LU0456846285.SGD","LU0516422952.EUR","LU0856984785.SGD","BK1521","LU0516423091.SGD","BK1161","LU0979878070.USD","LU0320764599.SGD","SG9999002562.SGD","LU0417516902.SGD","LU0588546209.SGD","LU1242518931.SGD","02269","LU0359201612.USD","KURE","LU0039217434.USD","LU0823426308.USD","06628","LU0140636845.USD","LU0348825331.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666383175","title":"Transcenta Holding - Grants WuXi Biologics Non-Exclusive License to Hicb Platform and Excelpro Cell Culture Media","url":"https://stock-news.laohu8.com/highlight/detail?id=2666383175","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666383175?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:00","pubTimestamp":1788955210,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA8NNVMW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0052750758.USD","LU0359201612.USD","IE00B0JY6N72.USD","BK1610","LU0456827905.SGD","BK1521","LU0856984785.SGD","02269","LU0359202008.SGD","LU0140636845.USD","KURE","LU0417516902.SGD","LU0516422952.EUR","LU0029874061.USD","LU2039709279.SGD","LU0819121731.USD","LU0588546209.SGD","LU0051755006.USD","LU0516423174.USD","LU0708995583.HKD","BK1576","LU0516423091.SGD","LU1880383366.USD","LU1688375341.USD","LU3063872942.SGD","LU0320764599.SGD","LU0823426308.USD","LU1794554557.SGD","LU0348735423.USD","LU0417516738.SGD","SG9999002562.SGD","LU0327786744.USD","06628","LU0823426480.USD","LU1242518857.USD","BK1589","LU0979878070.USD","LU0181495838.USD","LU0516422366.SGD","LU0348825331.USD","LU1242518931.SGD","LU0039217434.USD","LU1720050803.USD","LU0307460666.USD","LU0326950275.SGD","LU0456846285.SGD","LU0572944931.SGD","LU0128526141.USD","LU0516422440.USD","LU0043850808.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666587876","title":"CSPC Pharma Gets Clinical Trial Nod in China for Solid Tumors Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2666587876","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666587876?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:00","pubTimestamp":1788951640,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group's (HKG:1093) SYH9102 injection obtained clinical trial approval from China's National Medical Products Administration.The clinical indication is for patients with solid tumors, according to a Wednesday Hong Kong bourse filing.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01093","BK1521","LU0067412154.USD","LU1152091754.HKD","LU1226288253.USD","LU1226287875.USD","HK0000165453.HKD","LU1813983027.USD","BK1191","LU1960683339.HKD","IE0008368742.USD","LU0880133367.SGD","IE00B031HY20.USD","LU0314109678.HKD","LU2039709279.SGD","LU1951186391.HKD","LU1328277881.USD","LU1993786604.SGD","LU0140636845.USD","LU1008478684.HKD","IE00BZ08YR35.GBP","LU0072913022.USD","LU0326950275.SGD","SG9999004220.SGD","KURE","IE00BZ08YT58.USD","LU0315179316.USD","IE0008369823.USD","IE00BZ08YS42.EUR","LU1226287529.USD","IE00B5MMRT66.SGD","BK1515","IE00B543WZ88.USD","LU0501845795.SGD","LU1807302812.USD","LU1226288170.HKD","LU1226287792.SGD","LU1152091168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666828235","title":"CSPC Pharmaceutical Says Rotigotine Long-Acting Injection Gets Clinical Trial Approval in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2666828235","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666828235?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:34","pubTimestamp":1788950057,"startTime":"0","endTime":"0","summary":"BRIEF-CSPC Pharmaceutical Says Rotigotine Long-Acting Injection Gets Clinical Trial Approval In ChinaSept 9 (Reuters)-CSPC PHARMACEUTICAL GROUP LIMITED1093.HK:ROTIGOTINE LONG-ACTING INJECTION (SYH9087 INJECTION) OBTAINS CLINICAL TRIAL APPROVAL IN CHINAFurther company coverage:1093.HK","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nFWN45104B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1807302812.USD","IE00BZ08YT58.USD","BK1521","BK1191","01093","LU0072913022.USD","LU1226287529.USD","LU1226287875.USD","LU1226287792.SGD","LU1328277881.USD","LU0140636845.USD","LU1960683339.HKD","SG9999004220.SGD","LU0067412154.USD","IE00B543WZ88.USD","BK1515","LU1152091754.HKD","LU1152091168.USD","IE00B031HY20.USD","LU0326950275.SGD","LU0501845795.SGD","IE00B5MMRT66.SGD","LU1813983027.USD","LU0315179316.USD","LU1008478684.HKD","HK0000165453.HKD","LU1226288170.HKD","LU2039709279.SGD","LU0314109678.HKD","LU0880133367.SGD","LU1993786604.SGD","KURE","IE00BZ08YR35.GBP","IE0008368742.USD","IE00BZ08YS42.EUR","LU1226288253.USD","LU1951186391.HKD","IE0008369823.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151768833","title":"CSPC Pharma's Goserelin Extended-Release Injection Gets Clinical Trial Green Light in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1151768833","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151768833?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:12","pubTimestamp":1788948739,"startTime":"0","endTime":"0","summary":"CSPC PHARMA (01093) has announced that its self-developed gonadotropin-releasing hormone (GnRH) receptor agonist, Goserelin Extended-Release Injection (SYH9102 Injection), has received approval from...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0326950275.SGD","IE00BZ08YS42.EUR","LU1226287875.USD","LU0314109678.HKD","01093","IE0008368742.USD","BK1191","LU1226287792.SGD","LU1807302812.USD","IBBJ","LU1951186391.HKD","SG9999004220.SGD","IE0008369823.USD","KURE","LU1813983027.USD","IE00B031HY20.USD","LU1226288170.HKD","IE00BZ08YT58.USD","LU1993786604.SGD","IBBQ","PSYK","LU1152091754.HKD","HK0000165453.HKD","LU2039709279.SGD","LU0140636845.USD","LU1226287529.USD","BK1521","LU1960683339.HKD","MDTX","LU0067412154.USD","LU0315179316.USD","IE00B543WZ88.USD","LU0880133367.SGD","LU1226288253.USD","BMED","LU1152091168.USD","LU0072913022.USD","IE00B5MMRT66.SGD","LU0501845795.SGD","LU1328277881.USD","BK1515","LU1008478684.HKD","IE00BZ08YR35.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100647125","title":"CSPC Pharma Gains Chinese Clinical Trial Approval for Goserelin Extended-Release Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1100647125","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100647125?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:12","pubTimestamp":1788948739,"startTime":"0","endTime":"0","summary":"CSPC PHARMA (01093) has announced that its self-developed gonadotropin-releasing hormone (GnRH) receptor agonist, Goserelin Extended-Release Injection (SYH9102 Injection), has received approval from...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0067412154.USD","BK1191","LU1993786604.SGD","01093","IE00B543WZ88.USD","LU0315179316.USD","BMED","LU0314109678.HKD","LU0140636845.USD","LU1226287792.SGD","SG9999004220.SGD","IE00B031HY20.USD","BK1521","LU1951186391.HKD","LU1152091168.USD","PSYK","IE00BZ08YT58.USD","LU1008478684.HKD","LU0072913022.USD","LU0326950275.SGD","LU1152091754.HKD","IE00B5MMRT66.SGD","LU2039709279.SGD","IBBJ","MDTX","LU1226288170.HKD","LU1226287875.USD","IBBQ","LU0501845795.SGD","BK1515","KURE","LU1226288253.USD","LU0880133367.SGD","LU1328277881.USD","LU1807302812.USD","IE0008368742.USD","LU1813983027.USD","IE0008369823.USD","LU1960683339.HKD","LU1226287529.USD","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666610584","title":"CSPC Pharma Wins China Clinical Trial Clearance for Syh9102 Goserelin Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2666610584","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666610584?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:11","pubTimestamp":1788948662,"startTime":"0","endTime":"0","summary":"CSPC Pharma wins China clinical trial clearance for SYH9102 goserelin injectionCSPC Pharmaceutical Group received China NMPA clearance to start clinical trials of its goserelin sustained-release injec","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL9BYJhM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0326950275.SGD","LU1152091754.HKD","IE0008368742.USD","IE00B031HY20.USD","LU1807302812.USD","HK0000165453.HKD","IE00B5MMRT66.SGD","LU1993786604.SGD","BK1515","BK1191","LU1226287792.SGD","IE00BZ08YS42.EUR","IE00B543WZ88.USD","LU0072913022.USD","LU1152091168.USD","01093","IE0008369823.USD","LU1226287875.USD","LU0314109678.HKD","LU1960683339.HKD","LU1226287529.USD","SG9999004220.SGD","LU0067412154.USD","IE00BZ08YT58.USD","LU1951186391.HKD","LU1008478684.HKD","BK1521","LU1226288170.HKD","LU0140636845.USD","KURE","LU2039709279.SGD","LU1226288253.USD","LU1328277881.USD","IE00BZ08YR35.GBP","LU0880133367.SGD","LU0315179316.USD","LU0501845795.SGD","LU1813983027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666584556","title":"CSPC Pharmaceutical - Goserelin Sustained-Release Injection (Syh9102 Injection) Obtains Clinical Trial Approval in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2666584556","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666584556?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:07","pubTimestamp":1788948434,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nFWN450126:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1226288170.HKD","IE0008368742.USD","LU1960683339.HKD","LU1993786604.SGD","BK1521","LU1807302812.USD","LU1226287529.USD","IE0008369823.USD","IE00B031HY20.USD","IE00BZ08YT58.USD","HK0000165453.HKD","LU1008478684.HKD","BK1515","01093","LU0315179316.USD","IE00BZ08YR35.GBP","LU1328277881.USD","LU1152091754.HKD","LU0072913022.USD","LU0314109678.HKD","LU1226288253.USD","LU0067412154.USD","LU0326950275.SGD","LU1152091168.USD","LU1813983027.USD","KURE","LU1951186391.HKD","LU0501845795.SGD","LU1226287875.USD","BK1191","SG9999004220.SGD","LU2039709279.SGD","LU0880133367.SGD","LU0140636845.USD","IE00BZ08YS42.EUR","IE00B543WZ88.USD","IE00B5MMRT66.SGD","LU1226287792.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191216573","title":"CLSA Highlights Return of Stock-Specific Drivers in China's Innovative Drug Sector, Sees Macro Swings as Entry Points","url":"https://stock-news.laohu8.com/highlight/detail?id=1191216573","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191216573?lang=en_us&edition=fundamental","pubTime":"2026-09-09 14:06","pubTimestamp":1788933977,"startTime":"0","endTime":"0","summary":"China's innovative drug sector is swinging back to a market led by company fundamentals and stock-specific alpha, according to a research note from CLSA. The influence of particular company...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1589","BK1191","03692","KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665214203","title":"CSPC Pharmaceutical Gets China Approval for Eye Drug Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2665214203","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665214203?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:13","pubTimestamp":1788862439,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group's (HKG:1093) SYH2083 eye drops received approval from the National Medical Products Administration to begin clinical trials in China.The class 1 innovative drug is being developed for dry eye disease, according to a Tuesday Hong Kong bourse filing.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BZ08YT58.USD","LU1226287792.SGD","IE00B031HY20.USD","LU0326950275.SGD","LU1226287529.USD","SG9999004220.SGD","LU1152091168.USD","LU1993786604.SGD","LU1960683339.HKD","LU0072913022.USD","IE0008368742.USD","IE00B5MMRT66.SGD","IE0008369823.USD","IE00B543WZ88.USD","LU1951186391.HKD","IE00BZ08YR35.GBP","LU2039709279.SGD","LU1152091754.HKD","LU1807302812.USD","LU1226288170.HKD","LU1008478684.HKD","LU0314109678.HKD","BK1521","01093","LU1328277881.USD","LU0880133367.SGD","IE00BZ08YS42.EUR","BK1515","LU0501845795.SGD","LU0067412154.USD","LU1813983027.USD","KURE","LU0315179316.USD","LU1226287875.USD","LU1226288253.USD","LU0140636845.USD","HK0000165453.HKD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665329613","title":"CSPC Wins China Clinical Trial Approval for Syh2083 Dry Eye Drops","url":"https://stock-news.laohu8.com/highlight/detail?id=2665329613","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665329613?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:47","pubTimestamp":1788860844,"startTime":"0","endTime":"0","summary":"CSPC wins China clinical trial approval for SYH2083 dry eye dropsCSPC received China NMPA clearance to start clinical trials of SYH2083 eye drops, a small-molecule novel drug.Initial indication target","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL4D1fT5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1226287792.SGD","LU1951186391.HKD","BK1521","LU0072913022.USD","LU1226288170.HKD","BK1191","IE00B031HY20.USD","LU2039709279.SGD","IE00BZ08YT58.USD","IE0008368742.USD","LU0326950275.SGD","LU1152091168.USD","LU1813983027.USD","IE00BZ08YR35.GBP","LU1993786604.SGD","LU0067412154.USD","LU1226287529.USD","LU1226288253.USD","IE0008369823.USD","BK1515","LU1152091754.HKD","LU0315179316.USD","LU1226287875.USD","LU1008478684.HKD","SG9999004220.SGD","HK0000165453.HKD","LU0140636845.USD","IE00BZ08YS42.EUR","IE00B543WZ88.USD","LU1960683339.HKD","LU0880133367.SGD","LU1807302812.USD","01093","KURE","LU0501845795.SGD","LU0314109678.HKD","LU1328277881.USD","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665329660","title":"CSPC Pharmaceutical - Syh2083 Eye Drops Obtain Clinical Trial Approval in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2665329660","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665329660?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:47","pubTimestamp":1788860822,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nFWN44Z0GM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1807302812.USD","LU1226288253.USD","IE00B031HY20.USD","LU0501845795.SGD","LU1008478684.HKD","LU2039709279.SGD","LU0067412154.USD","IE00BZ08YT58.USD","LU0072913022.USD","SG9999004220.SGD","LU1152091754.HKD","IE00BZ08YS42.EUR","KURE","LU0140636845.USD","LU1226288170.HKD","LU1813983027.USD","IE0008369823.USD","01093","IE00B5MMRT66.SGD","LU0314109678.HKD","LU0880133367.SGD","BK1515","HK0000165453.HKD","LU1328277881.USD","BK1191","LU1152091168.USD","IE00BZ08YR35.GBP","LU1226287529.USD","LU1226287792.SGD","LU1951186391.HKD","IE00B543WZ88.USD","IE0008368742.USD","BK1521","LU1993786604.SGD","LU0326950275.SGD","LU1226287875.USD","LU0315179316.USD","LU1960683339.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665399325","title":"Wuxi Biologics (Cayman) Stock Climbs 1.7% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2665399325","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665399325?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:33","pubTimestamp":1788856380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. rose 1.7% to 49.30 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.4% to 25317.18.The stock's rise snapped a two-day losing streak.Wuxi Biologics  Inc. closed 9.5% short of its 52-week high of HK$54.45, which the company achieved Aug. 26.Trading volume totaled 22.4 million shares, compared to the 50-day average of 38.4 million shares.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1521","LU0588546209.SGD","LU1242518931.SGD","LU0052750758.USD","LU1794554557.SGD","LU2039709279.SGD","LU1688375341.USD","BK1141","LU1880383366.USD","LU0417516738.SGD","SG9999002562.SGD","LU0823426308.USD","LU0326950275.SGD","LU0348735423.USD","LU0708995583.HKD","LU0979878070.USD","LU0572944931.SGD","LU3063872942.SGD","LU0516423174.USD","LU0039217434.USD","LU0359201612.USD","SG9999002463.SGD","LU0516423091.SGD","LU0359202008.SGD","LU0417516902.SGD","LU0043850808.USD","LU1242518857.USD","LU0516422952.EUR","LU0051755006.USD","LU0348825331.USD","LU0823426480.USD","02269","LU0819121731.USD","LU1720050803.USD","LU0456846285.SGD","LU0140636845.USD","LU0516422440.USD","LU0029874061.USD","IE00B0JY6N72.USD","LU0456827905.SGD","LU0181495838.USD","BK1610","LU0320764599.SGD","LU0856984785.SGD","KURE","BK1589","BK1576","LU0516422366.SGD","LU0307460666.USD","LU0327786744.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665325339","title":"CSPC Pharmaceutical Group Stock Falls 2.7% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2665325339","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665325339?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:32","pubTimestamp":1788856320,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. slid 2.7% to 9.42 Hong Kong dollars on what proved to be an all-around rough trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.4% to 25317.18.This was the stock's second consecutive day of losses.CSPC Pharmaceutical Group Ltd. closed 19% short of its 52-week high of HK$11.63, which the company reached Sept. 9.The stock underperformed when compared to some of its competitors, as Sino Biopharmaceutical Ltd. rose 6.9%, SSY Group Ltd. fell 0.9%, and United Laboratories International Holdings Ltd. rose 0.5%.Trading volume totaled 71.8 million shares, compared to the 50-day average of 105.6 million shares.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1226288170.HKD","IE0008368742.USD","LU1960683339.HKD","LU1993786604.SGD","BK1521","LU1807302812.USD","LU1226287529.USD","IE0008369823.USD","IE00B031HY20.USD","IE00BZ08YT58.USD","HK0000165453.HKD","LU1008478684.HKD","BK1515","01093","LU0315179316.USD","IE00BZ08YR35.GBP","LU1328277881.USD","LU1152091754.HKD","LU0072913022.USD","LU0314109678.HKD","LU1226288253.USD","LU0067412154.USD","LU0326950275.SGD","LU1152091168.USD","LU1813983027.USD","KURE","LU1951186391.HKD","LU0501845795.SGD","LU1226287875.USD","BK1191","SG9999004220.SGD","LU2039709279.SGD","LU0880133367.SGD","LU0140636845.USD","IE00BZ08YS42.EUR","IE00B543WZ88.USD","IE00B5MMRT66.SGD","LU1226287792.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161695676","title":"Market Bets on BOJ Rate Hike While CICC's Merger Wins Regulatory Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1161695676","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161695676?lang=en_us&edition=fundamental","pubTime":"2026-09-08 07:46","pubTimestamp":1788824797,"startTime":"0","endTime":"0","summary":"The National Copyright Administration has issued the \"15th Five-Year Plan for Copyright Work,\" outlining key targets through 2030. The plan sets a national work registration target of 9.5 million...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXUS","IFLO","LU2663582299.SGD","LU0072913022.USD","OAKI","LU0501845795.SGD","09678","BK1501","PDEV","BK1249","LU0315179316.USD","CVIE","FNDC","BK1191","IE00BZ08YR35.GBP","SG9999004220.SGD","LU1993786604.SGD","IBFR","BK0276","BK1193","EFV","YDEC","BK4585","IE00B543WZ88.USD","TLTD","LU1807302812.USD","YJUN","RINT","EFAD","IE00B031HY20.USD","BK4588","JDVI","LU1226287792.SGD","IDLB","BK1109","IAUG","KCAI","DFAI","CGXU","DWM","IE00BZ08YS42.EUR","FNDF","NIHI","BK4550","FDT","AFDM","IAGG","IVSX","DFIV","FDEV","IBUF","IQLT","09976","HK0000165453.HKD","VDV","GWX","LU0880133367.SGD","BK1515","SG9999002828.SGD","IDVY","AVDE","LU0140636845.USD","LU0359201885.HKD","MTRA","GAID","HSCZ","IJUL","VIGI","LU1226287529.USD","DNL","IDYN","LU0067412154.USD","LU0326950275.SGD","BK1533","JIDE","LU1008478684.HKD","LU1580142542.USD","IE00BZ08YT58.USD","FIDI","LU1813983027.USD","BK1564","EFAV","WCMI","LU1508157978.USD","IE00B5MMRT66.SGD","HDMV","IDHQ","BK1149","DBAW","IE0008368742.USD","IDLV","BK1521","DFGX","IE0008369823.USD","IQDG","LU1781817850.SGD","REFA","BUFI","LU1226288170.HKD","LU1023057109.AUD","BK1147","LU0314109678.HKD","LU1328277881.USD","LU1951186391.HKD","BK1516","601995","LU1226287875.USD","NISM","NTSI","LU1960683339.HKD","PDN","PIEQ","DIVI","IFEB","EPIN","BK1122","LU0359201612.USD","LU1255011170.USD","LU1655091616.SGD","LU0359202008.SGD","BCIL","IJAN","03908","EFAS","LU2039709279.SGD","AVIV","OSEA","LU1152091168.USD","DISV","PJIO","QLVD","HJPX","DMRI","DIHP","LU1152091754.HKD","IDHD","RFDI","01093","KURE","LU1226288253.USD","JHMD","IQSI","PCIG","03308","BBIN","VXUS","IHDG","FEOE","HDEF","UIVM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665142623","title":"CSPC Pharma Begins Phase II Study of Influenza Drug in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2665142623","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665142623?lang=en_us&edition=fundamental","pubTime":"2026-09-07 21:11","pubTimestamp":1788786661,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group (HKG:1093) began a phase II clinical trial of SYH2085 tablets in China.The drug was developed by the company to treat uncomplicated influenza in adults, according to a Monday bourse filing.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0326950275.SGD","LU1152091754.HKD","IE0008368742.USD","IE00B031HY20.USD","LU1807302812.USD","HK0000165453.HKD","IE00B5MMRT66.SGD","LU1993786604.SGD","BK1515","BK1191","LU1226287792.SGD","IE00BZ08YS42.EUR","IE00B543WZ88.USD","LU0072913022.USD","LU1152091168.USD","01093","IE0008369823.USD","LU1226287875.USD","LU0314109678.HKD","LU1960683339.HKD","LU1226287529.USD","SG9999004220.SGD","LU0067412154.USD","IE00BZ08YT58.USD","LU1951186391.HKD","LU1008478684.HKD","BK1521","LU1226288170.HKD","LU0140636845.USD","KURE","LU2039709279.SGD","LU1226288253.USD","LU1328277881.USD","IE00BZ08YR35.GBP","LU0880133367.SGD","LU0315179316.USD","LU0501845795.SGD","LU1813983027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111207955","title":"Fourth Breakthrough Therapy Designation Granted to EGFR-Targeted ADC Developed by CSPC","url":"https://stock-news.laohu8.com/highlight/detail?id=1111207955","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111207955?lang=en_us&edition=fundamental","pubTime":"2026-09-07 21:01","pubTimestamp":1788786078,"startTime":"0","endTime":"0","summary":"On September 7th, the CDE website revealed that SYS6010, developed by CSPC PHARMA, has been proposed for inclusion in the breakthrough therapy designation program. This designation is intended for...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1993786604.SGD","LU2039709279.SGD","IE00BZ08YR35.GBP","LU1226288253.USD","LU1960683339.HKD","LU1152091754.HKD","LU1226288170.HKD","01093","BK1521","LU1226287529.USD","LU1226287875.USD","LU0072913022.USD","BK1515","IE00B5MMRT66.SGD","LU1951186391.HKD","BK1191","LU1807302812.USD","LU0315179316.USD","IE00B031HY20.USD","IE00BZ08YS42.EUR","LU0501845795.SGD","HK0000165453.HKD","IE0008368742.USD","LU0314109678.HKD","SG9999004220.SGD","LU0326950275.SGD","LU1008478684.HKD","LU1328277881.USD","LU0067412154.USD","LU1152091168.USD","LU1226287792.SGD","KURE","LU0140636845.USD","IE00B543WZ88.USD","IE0008369823.USD","LU0880133367.SGD","IE00BZ08YT58.USD","LU1813983027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665145523","title":"WuXi Biologics Files HKEX Next-Day Disclosure Return, Issues 1,804,090 New Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2665145523","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665145523?lang=en_us&edition=fundamental","pubTime":"2026-09-07 20:53","pubTimestamp":1788785616,"startTime":"0","endTime":"0","summary":"WuXi Biologics files HKEX next-day disclosure return, issues 1,804,090 new sharesWuXi Biologics filed a next-day disclosure return on Sept. 7, 2026 following option exercises under its pre-IPO share o","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nNDL8NH0rN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0326950275.SGD","LU0456827905.SGD","LU0320764599.SGD","BK1589","LU0359201612.USD","LU0417516902.SGD","LU0572944931.SGD","LU0516423091.SGD","LU1688375341.USD","LU1242518857.USD","SG9999002463.SGD","BK1141","LU0307460666.USD","LU0417516738.SGD","LU0052750758.USD","LU1720050803.USD","SG9999002562.SGD","BK1576","LU1794554557.SGD","LU0516422952.EUR","LU0128526141.USD","LU0979878070.USD","LU0051755006.USD","LU0516422440.USD","LU0708995583.HKD","LU1880383366.USD","LU0348735423.USD","LU3063872942.SGD","LU0856984785.SGD","LU0823426308.USD","LU0819121731.USD","02269","BK1521","LU0029874061.USD","LU0327786744.USD","LU0140636845.USD","KURE","LU0359202008.SGD","IE00B0JY6N72.USD","LU0588546209.SGD","LU2039709279.SGD","LU0043850808.USD","LU0181495838.USD","LU0823426480.USD","LU1242518931.SGD","LU0456846285.SGD","LU0516422366.SGD","LU0348825331.USD","LU0039217434.USD","LU0516423174.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199113939","title":"CSPC Pharma Initiates Phase II Trial of SYH2085 Tablet for Uncomplicated Influenza in Chinese Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=1199113939","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199113939?lang=en_us&edition=fundamental","pubTime":"2026-09-07 19:36","pubTimestamp":1788780985,"startTime":"0","endTime":"0","summary":"CSPC Pharma (01093) has announced that the Phase II clinical trial of its SYH2085 tablet, designed for the treatment of uncomplicated influenza in adults, has formally commenced at the first clinical...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0008369823.USD","IE00BZ08YT58.USD","LU1226287792.SGD","IE00BZ08YR35.GBP","LU1226287875.USD","LU1226288170.HKD","01093","LU0314109678.HKD","LU0880133367.SGD","LU0067412154.USD","LU1993786604.SGD","LU0140636845.USD","LU1226288253.USD","BMED","BK1515","LU1152091168.USD","LU1807302812.USD","LU1008478684.HKD","LU1813983027.USD","LU0501845795.SGD","LU0326950275.SGD","PSYK","LU1960683339.HKD","IBBJ","IE00B5MMRT66.SGD","KURE","LU0072913022.USD","IE00B543WZ88.USD","MDTX","IBBQ","LU0315179316.USD","LU1152091754.HKD","LU1951186391.HKD","SG9999004220.SGD","BK1191","BK1521","IE00BZ08YS42.EUR","HK0000165453.HKD","IE0008368742.USD","LU2039709279.SGD","LU1226287529.USD","LU1328277881.USD","IE00B031HY20.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}